Deoxycholic acid, or DCA, is a secondary bile acid, meaning it is produced when gut bacteria chemically modify primary bile acids that were first made in the liver. Its parent compound, cholic acid, is converted in the intestine through a bacterial process called 7-dehydroxylation. Once formed, DCA is absorbed back into the bloodstream, carried to the liver, and recycled into bile. This recycling system, called the enterohepatic circulation, helps maintain a steady pool of bile acids in the body.
DCA’s primary physiological role is to aid in fat digestion and cholesterol balance. Like other bile acids, it acts as a detergent that helps break dietary fats into smaller droplets so digestive enzymes can work more efficiently. Beyond digestion, DCA also functions as a signaling molecule that interacts with receptors in the liver, intestine, and immune system. Through these pathways, it can influence how much energy the body burns, how blood sugar is managed, and how the immune system responds to microbes.
At moderate levels, DCA may support metabolic health. Animal studies suggest it can increase fat breakdown (lipolysis), boost heat production (thermogenesis), and improve insulin sensitivity, which is the body’s ability to respond effectively to insulin. Some evidence even points to a role in shaping the gut microbiome and protecting against harmful bacteria, since DCA has antimicrobial effects that can suppress the growth of certain pathogens.
The challenge with DCA is that too much of it can shift from helpful to harmful. High levels of DCA have been linked to inflammation, gut barrier disruption, and liver injury, particularly in conditions such as non-alcoholic fatty liver disease (NAFLD). In the colon and stomach, excess DCA can damage DNA and promote cancer development by increasing oxidative stress, impairing the tumor-suppressor protein p53, and suppressing immune surveillance. Clinical studies consistently connect elevated DCA with higher risk of colorectal and gastric cancers.
Not all elevated DCA indicates disease, however. For example, temporary shifts in gut microbiota after antibiotics or dietary changes can raise DCA without leading to pathology. Similarly, differences in bile acid recycling from person to person can produce natural variation in levels. This makes context, such as accompanying liver markers, gut symptoms, and overall bile acid balance, critical in interpreting its significance.